<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: eye problem</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Novartis tries to make UK hospitals use $1000 drug</title>
   	 <description>(AP) --  Drug maker Novartis says it is taking legal action in Britain to make hospitals use an eye drug that costs 700 pounds ($1,130) per shot instead of a cheaper one that costs 60 pounds ($97).</description>
     <link>http://medicalxpress.com/news/2012-04-novartis-uk-hospitals-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 24 Apr 2012 07:35:08 EST</pubDate>
	 <guid isPermaLink="false">news254471681</guid>
	 
</item>
<item>
     <title>Optometry experts prove the effectiveness of orthokeratology in myopic control</title>
   	 <description>After a lengthy study spanning over four years, Professor Pauline Cho from the School of Optometry at The Hong Kong Polytechnic University (PolyU) and her research team concluded that orthokeratology not only can correct refractive error, but also effective in slowing the progression of myopia.</description>
     <link>http://medicalxpress.com/news/2012-01-optometry-experts-effectiveness-orthokeratology-myopic.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 11 Jan 2012 08:40:51 EST</pubDate>
	 <guid isPermaLink="false">news245493632</guid>
	 
</item>


</channel>
</rss>
